Search for the latest oncology news by tumour type
New data from Cohort 2 of the Phase 2b SunRISe-1 study evaluating TAR-200—an intravesical gemcitabine…
Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in identifying…
An ultrasensitive circulating tumour DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence before imaging…
A new study published in JAMA Oncology evaluates the potential benefits and costs of introducing…
On April 23, 2025, the Food and Drug Administration approved penpulimab-kcqx with cisplatin or carboplatin…
Glioblastoma multiforme is an aggressive brain tumour that mainly affects adults. Approximately 30,000 people in…
Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one…
Breast cancer is becoming increasingly treatable, but in some cases, the disease can resurface even…
Prostate cancer has distinct genetic properties in different groups of men that can be targeted to…
Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of…